TELA Bio, Inc. (TELA) Total liabilities 2018–2025
TELA Bio, Inc. (TELA) total liabilities at each fiscal year-end, per SEC filings.
$75.1MFY2025 · since FY2018: $40.9M → $75.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.1M | +29.2% |
| FY2024 | $58.1M | -1.8% |
| FY2023 | $59.2M | +10.5% |
| FY2022 | $53.5M | +26.2% |
| FY2021 | $42.4M | +13.4% |
| FY2020 | $37.4M | +1.3% |
| FY2019 | $37.0M | -9.7% |
| FY2018 | $40.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TELA financial trends
TELA RevenueTELA Net incomeTELA Net marginTELA Gross profitTELA Gross marginTELA Operating incomeTELA Operating marginTELA Operating cash flowTELA Free cash flowTELA Capital expendituresTELA Return on equityTELA Stock buybacksTELA Dividends paidTELA Total assetsTELA Shareholders’ equityTELA overview →